Granted Patent
B2
US 9,930,893 · App. 14/618,589 · Granted Apr 3, 2018
Inhibitors of DXP synthase and methods of use thereof
Inventors:
Caren L. Freel Meyers (Towson, MD); Francine Morris (Philadelphia, PA); Ryan J. Vierling (Baltimore, MD)
Assignee:
The Johns Hopkins University
View Patent ↗
Loading inventors, assignments & file history…
Abstract
Novel inhibitors of DXP synthase and methods of use thereof are disclosed.
Claims (7)
1. A pharmaceutical composition comprising a compound represented by the formula:
in which
X is phenyl;
R 1 , independently is absent, or if present, is halo or optionally substituted C 1 -C 4 alkyl; and,
n is 1;
or a pharmaceutically acceptable salt thereof, together with a pharmaceutically acceptable carrier.
2. The pharmaceutical composition of claim 1 , wherein the pharmaceutical composition comprises:
Assignments (2)
CONFIRMATORY LICENSE
Recorded Feb 27, 2018
From: JOHNS HOPKINS UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 045450/0714 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Feb 13, 2018
From: FREEL MEYERS, CAREN L.; VIERLING, RYAN J.
To: THE JOHNS HOPKINS UNIVERSITY
Reel/Frame 044912/0507 →
Continuity (2)
Provisional Application
61938114
· Feb 10, 2014